Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Probation Termination topic
No spam. Unsubscribe anytime.
Long-running disciplinary petition: Sheldon Boorson tells board recovery program changed his life; seeks early termination and cost relief
Summary
Sheldon Boorson Jr., disciplined after investigations at Albertsons and Costco, told the Board of Pharmacy committee Dec. 18 he completed extended recovery monitoring and has complied with probation conditions but seeks waiver of remaining costs so probation can end.
Sheldon Boorson Jr., whose discipline stems from allegations of diversion and prescription irregularities between 2007 and 2011, told the Board’s disciplinary petition committee on Dec. 18 that participation in a lengthy recovery and monitoring program has changed his life and supported his return to steady employment.
Deputy Attorney General Nicole Trauma summarized the underlying accusations, which include allegations that Boorson diverted controlled substances while he was pharmacist in charge at an Albertsons store and later at a Costco pharmacy, improperly dispensed or refilled controlled-substance prescriptions for himself and others, and failed to maintain adequate controls. The administrative decision effective Oct. 28, 2013 revoked the license but stayed the revocation and imposed nine years of probation; Boorson’s probation would have ended in Feb. 2022 but for outstanding costs.
Trauma told the committee the petitioner has paid a significant portion of costs and complied with quarterly reporting, monitoring and testing, supervision requirements, community service and ethics training; his remaining account balance was identified as $26,038.60 in the hearing record. The petition packet (admitted as Exhibit 1) contains four verified letters of recommendation and medical and recovery documentation; the committee granted a protective order to seal limited medical and recovery progress records in the packet from public disclosure.
Boorson testified he spent years in the Maximus recovery program, participated in intensive therapeutic work and long-term monitoring, never failed a drug test and has been employed full time for the last seven years. He described bankruptcy and substantial financial losses tied to his treatment and recovery, and he asked the board to consider waiving or reducing the remaining balance so probation can terminate.
Board members asked detailed questions about timelines, the scope of monitoring, the cost burden of long-term testing, and whether completed monitoring and testing justified early termination or cost relief. Boorson emphasized he had been drug testing for more than a decade and that continued testing costs have impeded repayment of the outstanding balance.
After closing arguments the committee admitted the petition packet and took the matter under submission; no decision was announced on the public record. The committee will meet in closed session and the petitioner will receive the board’s written decision in several months.
